JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tytgat, J.
Right arrow Articles by Carmeliet, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tytgat, J.
Right arrow Articles by Carmeliet, E.

Mechanism of cardiac T-type Ca channel blockade by amiloride

J Tytgat, J Vereecke and E Carmeliet

Laboratory of Physiology, KU Leuven, Campus Gasthuisberg, Belgium.

Whole cell clamp experiments were used to study the mechanism of action of amiloride on cardiac T-type Ca channels in guinea pig ventricular myocytes. Two hundred fifty microM amiloride blocked the T-type Ca channel for approximately 50%, whereas this concentration did not suppress the L-type Ca channel. The Kd value for the block of the T- type Ca channel was 233 microM and the Hill coefficient was 1.1. The drug showed a rapid onset of action and a quick wash out with complete reversibility. Amiloride blocked the T-type Ca channel without frequency-dependency, i.e., block was established at the holding potential (-90 mV) without being dependent on activation and inactivation of the channel. Amiloride reduced the amplitude of the T- type Ca current at all potentials without changing steady-state activation and inactivation. Amiloride did not affect the T-type Ca current when the drug was applied intracellularly via the pipette solution. In summary, amiloride blocked the T-type Ca channel in a channel state- and voltage-independent way.

Volume 254, Issue 2, pp. 546-551, 08/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
X.-Q. Dai, A. Ramji, Y. Liu, Q. Li, E. Karpinski, and X.-Z. Chen
Inhibition of TRPP3 Channel by Amiloride and Analogs
Mol. Pharmacol., December 1, 2007; 72(6): 1576 - 1585.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Wang, A. Bhattacharjee, Z. Zuo, F. Hu, R. E. Honkanen, P.-O. Berggren, and M. Li
A Low Voltage-Activated Ca2+ Current Mediates Cytokine-Induced Pancreatic {beta}-Cell Death
Endocrinology, March 1, 1999; 140(3): 1200 - 1204.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
C. Arnoult, M. Villaz, and H. M. Florman
Pharmacological Properties of the T-Type Ca2+ Current of Mouse Spermatogenic Cells
Mol. Pharmacol., June 1, 1998; 53(6): 1104 - 1111.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.